Alfredo Carrato
机构: Medical Oncology Emeritus Professor, Alcalá University. Pancreatic Cancer Europe Chair. IRYCIS
每年引用次数
引用次数
引用: 23,394
H-指数: 74
I10-指数 : 264
出版物: 759
Abstract P1-01-12: Comparison of local clinical subtyping to central molecular classification using microarray-based expression test in breast cancer patients
M Fernández-Abad , A Cortés-Salgado , N Martínez-Jáñez , P Cortez-Castedo
Cancer Research 76
2016
112P Immunogenicity of the mRNA-1273 SARS-CoV-2 vaccine in cancer patients receiving immunotherapy agents
F Longo Muñoz , A Cortés Salgado , JJ Serrano Domingo , JL Casado
Annals of Oncology 32 S1424 -S1424
2021
IFN-gamma-regulated expression of a differentiation antigen of human cells.
H F Oettgen , S Welt , F X Real , M H Schuessler
Journal of Immunology 140 ( 5) 1571 -1576
5
1988
UFT plus or minus calcium folinate for metastatic colorectal cancer in older patients.
T Massuti , A Carrato , E Marcuello , E Díáz-Rubio
Oncology 13 ( 7) 35 -40
19
1999
Blood vessel's wall and neurosecretion at the neurohypophysis.
A Carrato
Trabajos del Instituto Cajal de investigaciones biologicas 65 41 -61
1973
Comparative activity of navelbine, navelbine + cisplatin, and vin-desine + cisplatin in the therapy of unresectable non small cell lung carcinoma. Results of a multicentric European randomized trial including 612 patients
A Carrato , V Alberola , JL Gonzalez Larriba , P Lianes
Lung Cancer 3 ( 12) 307
1995
SEOM clinical guidelines for pancreatic and biliary tract cancer (2020)
A Carrato , A M Martín , J Maurel , J Feliu
Clinical & Translational Oncology 23 ( 5) 988 -1000
19
2021
Multidrug resistance-associated protein (MRP1) gene is strongly expressed in gastric carcinomas. Analysis by immunohistochemistry and real-time quantitative RT-PCR.
J Lacueva , M Perez‐Ramos , JL Soto , I Oliver
Histopathology 46 ( 4) 389 -395
15
2005
Gender-related differences in clinical and pathological characteristics and therapy of bladder cancer.
D Puente , N Malats , L Cecchini , A Tardón
European Urology 43 ( 1) 53 -62
47
2003
Randomized trial of high-dose epirubicin-cisplatin (HDEP) versus etoposide-cisplatin (EP) in small cell lung cancer (SCLC). Study retrospective in older patients
C Camps , A Artal , J Gomez-Codina , J.L Gonzalez-Larriba
Lung Cancer 29 ( 1) 42
1
2000
Assessment of tubulin mutations in a phase II study of biweekly gemcitabine/paclitaxel (T) in advanced non-small-cell lung cancer (NSCLC)
R Rosell , A O'Brate , J Sánchez , D Isla
Lung Cancer 29 ( 1) 49
2000
Preliminary results of sequential dose-dense paclitaxel followed by topotecan in extensive small-cell lung cancer (SCLC): A phase II study
E Felip , A Font , R Rosell , P Garrido
Lung Cancer 29 ( 1) 51 -52
1
2000
Phase II study of an intensive single dose of irinotecan (CPT-11) and cisplatin (CDDP) every three weeks, in patients with advanced non-small cell lung cancer
M Dómine , F Cardenal , B Massuti , A Carrato
Lung Cancer 29 ( 1) 55
2
2000
UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy
E Martinez-Balibrea , A Abad , A Martínez-Cardús , A Ginés
British Journal of Cancer 103 ( 4) 581 -589
71
2010
Occupation and Bladder Cancer in a Hospital-Based Case-Control Study in Spain
C M Samanic , M Kogevinas , D T Silverman , A Tardon
Occupational and Environmental Medicine 65 ( 5) 347 -353
58
2008
Elderly colorectal cancer patients are under treated
P Rougier , E Mitry , E Aranda , B Daniele
Ejc Supplements 2 ( 7) 8 -13
5
2004
Refinement of screening for familial pancreatic cancer
D K Bartsch , E P Slater , A Carrato , I S Ibrahim
Gut 65 ( 8) 1314 -1321
46
2016
PCN110 RESOURCE UTILIZATION AND DIAGNOSTIC APPROACHES IN NON-SMALL-CELL LUNG CANCER (NSCLC) ACROSS EUROPE: EPICLIN-LUNG STUDY
A Vergnenegre , G Cruciani , M Thomas , E Guallar
Value in Health 13 ( 7)
2010
PCN133 EPICLIN-LUNG STUDY: NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENT QUALITY OF LIFE AND HEALTH-STATE ASSESSMENT
M Thomas , G Cruciani , A Vergnenegre , E Guallar
Value in Health 13 ( 7)
2010
Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives.
E Molina-Montes , P Gomez-Rubio , M Márquez , M Rava
International Journal of Epidemiology 47 ( 2) 473 -483
18
2018